Hypokalemia, hyperglycemia and plasma catecholamine activity after severe theophylline intoxication. 1994

M Shannon
Division of Emergency Medicine, Children's Hospital, Boston, Massachusetts 02115.

To determine if differences in the rate of hypokalemia and hyperglycemia between victims of acute versus chronic theophylline intoxication relate to alterations in plasma catecholamine activity, we evaluated plasma catechols in three groups of patients: victims of acute theophylline intoxication (n = 10), chronic theophylline overmedication (n = 3), and healthy controls (n = 6). There were no differences in peak serum theophylline concentration between acute and chronic groups (86.6 vs 73.0 mcg/mL, p = NS). Among those with acute intoxication mean (+/- SEM) serum potassium was 2.80 +/- .16 mEq/L while mean serum glucose was 208 +/- 26 mg/dL. In contrast, those with chronic intoxication had a mean serum potassium of 4.10 +/- .70 mEq/L with a mean serum glucose of 139 mg/dL (p < .0001 and p < .04 for between-group potassium and glucose, respectively). Potassium and glucose concentrations of those with chronic theophylline intoxication were similar to those of controls. Plasma epinephrine was higher in those with acute theophylline intoxication than in victims of chronic overmedication and controls (282 vs 133 vs 58 pg/mL, p < .003). Plasma norepinephrine and dopamine in contrast were significantly higher in those with chronic overmedication than in those with acute intoxication and controls (norepinephrine 1395 vs 965 vs 268 pg/mL, p < .008; dopamine 198 vs 148 vs 39 pg/mL, p < .009). These data suggest that the pattern of glucose and potassium disturbances after acute theophylline intoxication parallel differences in plasma epinephrine concentrations. This supports theories that hypokalemia is the result of enhanced beta-2 receptor stimulation.

UI MeSH Term Description Entries
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Shannon
September 1985, The American journal of emergency medicine,
M Shannon
July 1987, The Journal of pediatrics,
M Shannon
October 2003, Nephrology (Carlton, Vic.),
M Shannon
January 1994, Presse medicale (Paris, France : 1983),
M Shannon
January 2008, Revue medicale de Bruxelles,
M Shannon
January 1982, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement,
M Shannon
January 1980, Developmental pharmacology and therapeutics,
Copied contents to your clipboard!